Mark C Wiggins is Chief Business Officer of Tracon Pharmaceuticals, Inc.. Currently has a direct ownership of 13,700 shares of TCON, which is worth approximately $411. The most recent transaction as insider was on Dec 29, 2020, when has been sold 1,000 shares (Common Stock) at a price of $10.57 per share, resulting in proceeds of $10,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.7K
0% 3M change
0% 12M change
Total Value Held $411

MARK C WIGGINS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 29 2020
BUY
Open market or private purchase
$10,570 $10.57 p/Share
1,000 Added 6.8%
13,700 Common Stock

Also insider at

ZGNX
ZOGENIX, INC.
MCW

Mark C Wiggins

Chief Business Officer
San Diego, CA

Track Institutional and Insider Activities on TCON

Follow Tracon Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCON shares.

Notify only if

Insider Trading

Get notified when an Tracon Pharmaceuticals, Inc. insider buys or sells TCON shares.

Notify only if

News

Receive news related to Tracon Pharmaceuticals, Inc.

Track Activities on TCON